Entries tagged "FDA"

You have executed a tag search on The Deal Pipeline. Below, you will find a comprehensive list of stories tagged "FDA."

12 result(s) displayed (1 - 12 of 24)

Affymax reviews options including bankruptcy after recall

The company's first and only approved drug, anemia treatment Omontys, is linked to three deaths. Continue reading

Posted on March 19, 2013 1:40 PM

Omthera IPO adds big fish to heart drug pond

Company looks to capture market share from Glaxo and Amarin with Epanova medicine. Continue reading

Posted on March 12, 2013 9:20 AM

Allergan pays steep premium for migraine specialist

The drugmaker will acquire MAP Pharmaceuticals in deal that values the target's equity at $958 million, giving analysts who follow the buyer an aching head. Continue reading

Posted on January 23, 2013 4:20 PM

Teva aims to unloose more dollars for restructuring

The Israeli drug giant's CEO tells attendees at the JPMorgan Healthcare Conference that the company is surveying all nonlabor expenditures to find efficiencies that would yield cash it would use on fewer therapeutic areas. Continue reading

Posted on January 10, 2013 2:21 PM

Putting a price on promise

The complex world of pharmaceutical collaborations and partnerships is the most active and evolving area of life sciences dealmaking -- and the least transparent. Continue reading

Posted on January 4, 2013 3:23 PM

Obesity drugmaker raises more venture funding

Alta Partners, Atlas Venture and Third Rock Ventures provide a $21 million Series D equity financing to Zafgen, which has just initated Phase 2a trials for its promising therapy called beloranib. Continue reading

Posted on December 6, 2012 2:47 PM

Affordable Care Act is here to stay

The president's victory means the ACA is here to stay, so drug companies and device makers are taking stock in what, exactly, that means. Continue reading

Posted on November 12, 2012 8:26 AM

Under the radar

The Obama administration has touched bankruptcy outside of Solyndra. Continue reading

Posted on October 18, 2012 4:32 PM

Idenix slapped with second FDA hold

The ripple effects of Bristol-Myers' Inhibitex problems continue Continue reading

Posted on August 27, 2012 2:26 PM

Sarepta shares surge on drug breakthrough

After the company releases positive Phase 2b data on eteplirsen, a compound that treats Duchenne muscular dystrophy, talk turns to the possibility of a takeover Continue reading

Posted on July 25, 2012 9:22 AM

Bleeding cash, K-V sues FDA

The pharmaceutical company says pressures over its list price are keeping its pregnancy drug from selling more. Continue reading

Posted on July 12, 2012 10:18 AM

Forest fires back at Icahn

The pharmaceutical company files a broadside ahead of an Aug. 15 meeting Continue reading

Posted on July 10, 2012 4:00 AM

Movable Type search results powered by Fast Search